SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurinia Pharmaceuticals Inc. - AUPH Pharmaceutical Investing
Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers Pharmaceutical Investing
Ortho Dermatologics Now Accepting Applications for 2022 Aspire Higher Scholarship Program Pharmaceutical Investing
Pfizer Granted FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV in Infants from Birth up to Six Months of Age by Active Immunization of Pregnant Women Life Science Investing
Bristol Myers Squibb Announces Early Participation Results, Upsizing and Early Settlement of Tender Offers Pharmaceutical Investing
Dragonfly Therapeutics Announces Achievement of Phase 1 Clinical Development Milestone for IL-12 Investigational Immunotherapy Program with Bristol Myers Squibb Pharmaceutical Investing
Gilead Receives Complete Response Letter From U.S. FDA for Investigational Lenacapavir Due to Vial Compatability Issues Pharmaceutical Investing
Cardiol Therapeutics Receives Clearance from the FDA and Regulatory Agencies in Brazil and Mexico for Important Protocol Amendments Designed to Expedite Patient Enrollment in the LANCER Trial Pharmaceutical Investing
